Michael David
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 47
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 72
- Clostridium difficile and Clostridium perfringens research 9
-
- Antibiotic Use and Resistance 11
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 7
- Microbiology top 1%
-
- Streptococcal Infections and Treatments 29
-
- Bacterial biofilms and quorum sensing 14
-
- Sepsis Diagnosis and Treatment 9
- Co-authors
- Robert S. DaumSusan Boyle‐VavraRichard WatkinsLoren G. MillerMargaret CarrelEli N. PerencevichDiane S. LauderdaleIan M. Gould
- Journals
- Clinical Infectious Diseases (11 papers)Open Forum Infectious Diseases (10 papers)Infection Control and Hospital Epidemiology (10 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Michael David
125 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Clinical Biochemistry 1.5k
- Infectious Diseases 3.2k
- Applied Microbiology and Biotechnology 208
- Molecular Medicine 424
- Microbiology 386
Countries citing papers authored by Michael David
This map shows the geographic impact of Michael David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael David more than expected).
Fields of papers citing papers by Michael David
This network shows the impact of papers produced by Michael David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael David. The network helps show where Michael David may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 12 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 1 | |
| 12 | 2018 | 11 | |
| 13 | 2018 | 31 | |
| 14 | 2015 | 79 | |
| 15 | 2014 | 6 | |
| 16 | 2013 | 101 | |
| 17 | 2012 | 9 | |
| 18 | 2012 | 157 | |
| 19 | 1998 | 45 | |
| 20 | 1987 | 30 |
About Michael David
Michael David is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine and Public Health, Environmental and Occupational Health, having authored 130 papers that have together received 4.8k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (72 papers), Bacterial Identification and Susceptibility Testing (47 papers), Streptococcal Infections and Treatments (29 papers), Bacterial biofilms and quorum sensing (14 papers), Antibiotic Use and Resistance (11 papers), Clostridium difficile and Clostridium perfringens research (9 papers), Sepsis Diagnosis and Treatment (9 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Clinical Biochemistry (1.5k citations), Infectious Diseases (3.2k citations), Applied Microbiology and Biotechnology (208 citations), Molecular Medicine (424 citations) and Microbiology (386 citations). Michael David has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Robert S. Daum, Susan Boyle‐Vavra, Richard Watkins, Loren G. Miller, Margaret Carrel, Eli N. Perencevich, Diane S. Lauderdale, Ian M. Gould, Robert A. Salata and Samantha J. Eells. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Journal of Clinical Microbiology and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.